Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Company Holds IPO Pricing Range. More details...
Drug Extends Survival In Liver Cancer. More details...
CBT 200 Falls 20 Points. More details...
CBT 200 Climbs 34 Points. More details...
Nexavar Revenues Beat Estimates. More details...
CBT 200 Up Ever So Slightly. More details...
CBT 200 Slips 4 Points Lower. More details...
CBT 200 Sinks 25 Points Lower. More details...
Chinese Rights To TNT Therapy In Dispute -- Cancer...
CBT 200 Climbs 20 Points Higher. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China